XML 32 R19.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair Value Measurements Level 3 (Tables)
6 Months Ended
Jun. 30, 2016
Fair Value Disclosures [Abstract]  
Assets and (liabilities) carried at fair value by hierarchy level
 
June 30, 2016
 
Total
Quoted Prices in Active Markets for Identical Assets (Level 1)
Significant Observable Inputs (Level 2)
Significant Unobservable Inputs (Level 3)
Assets accounted for at fair value on a recurring basis
 
 
 
 
Fixed maturities, AFS
 
 
 
 
ABS
$
1,019

$

$
1,012

$
7

CDOs
1,269


1,003

266

CMBS
2,146


2,131

15

Corporate
15,594


14,877

717

Foreign government/government agencies
296


278

18

Municipal
1,282


1,209

73

RMBS
1,732


1,042

690

U.S. Treasuries
2,362

299

2,063


Total fixed maturities
25,700

299

23,615

1,786

Fixed maturities, FVO
123


123


Equity securities, trading [1]
11

11



Equity securities, AFS
136

52

42

42

Derivative assets
 
 
 
 
Credit derivatives
12


12


Foreign exchange derivatives
1


1


Interest rate derivatives
123


123


Guaranteed minimum withdrawal benefit ("GMWB") hedging instruments
85


(2
)
87

Macro hedge program
49



49

Total derivative assets [2]
270


134

136

Short-term investments
874

258

616


Limited partnerships and other alternative investments [5]
5




Reinsurance recoverable for GMWB
106



106

Modified coinsurance reinsurance contracts
32


32


Separate account assets [3]
114,607

73,805

39,605

171

Total assets accounted for at fair value on a recurring basis
$
141,864

$
74,425

$
64,167

$
2,241

Liabilities accounted for at fair value on a recurring basis
 
 
 
 
Other policyholder funds and benefits payable
 
 
 
 
GMWB
$
(412
)
$

$

$
(412
)
Equity linked notes
(28
)


(28
)
Total other policyholder funds and benefits payable
(440
)


(440
)
Derivative liabilities
 
 
 
 
Credit derivatives
(21
)

(21
)

Equity derivatives
28


27

1

Foreign exchange derivatives
(281
)

(281
)

Interest rate derivatives
(447
)

(413
)
(34
)
GMWB hedging instruments
118


40

78

Macro hedge program
98


6

92

Total derivative liabilities [4]
(505
)

(642
)
137

Total liabilities accounted for at fair value on a recurring basis
$
(945
)
$

$
(642
)
$
(303
)
 
December 31, 2015
 
Total
Quoted Prices in Active Markets for Identical Assets (Level 1)
Significant Observable Inputs (Level 2)
Significant Unobservable Inputs (Level 3)
Assets accounted for at fair value on a recurring basis
 
 
 
 
Fixed maturities, AFS
 
 
 
 
ABS
$
846

$

$
841

$
5

CDOs
1,408


1,078

330

CMBS
1,964


1,902

62

Corporate
15,175


14,641

534

Foreign government/government agencies
331


314

17

Municipal
1,132


1,083

49

RMBS
1,503


875

628

U.S. Treasuries
2,298

123

2,175


Total fixed maturities
24,657

123

22,909

1,625

Fixed maturities, FVO
165

1

162

2

Equity securities, trading [1]
11

11



Equity securities, AFS
459

396

25

38

Derivative assets
 
 
 
 
Credit derivatives
7


7


Foreign exchange derivatives
4


4


Interest rate derivatives
54


54


GMWB hedging instruments
111


27

84

Macro hedge program
74



74

Total derivative assets [2]
250


92

158

Short-term investments
572

131

441


Reinsurance recoverable for GMWB
83



83

Modified coinsurance reinsurance contracts
79


79


Separate account assets [3]
118,163

78,099

38,700

140

Total assets accounted for at fair value on a recurring basis
$
144,439

$
78,761

$
62,408

$
2,046

Liabilities accounted for at fair value on a recurring basis
 
 
 
 
Other policyholder funds and benefits payable
 
 
 
 
GMWB
$
(262
)
$

$

$
(262
)
Equity linked notes
(26
)


(26
)
Total other policyholder funds and benefits payable
(288
)


(288
)
Derivative liabilities
 
 
 
 
Credit derivatives
(7
)

(7
)

Equity derivatives
41


41


Foreign exchange derivatives
(376
)

(376
)

Interest rate derivatives
(431
)

(402
)
(29
)
GMWB hedging instruments
47


(4
)
51

Macro hedge program
73



73

Total derivative liabilities [4]
(653
)

(748
)
95

Total liabilities accounted for at fair value on a recurring basis
$
(941
)
$

$
(748
)
$
(193
)
[1]
Included in other investments on the Condensed Consolidated Balance Sheets.
[2]
Includes over-the-counter ("OTC") and OTC-cleared derivative instruments in a net positive fair value position after consideration of the accrued interest and impact of collateral posting requirements which may be imposed by agreements, clearing house rules and applicable law. See the following footnote 4 for derivative liabilities.
[3]
Approximately $3.2 billion and $1.8 billion of investment sales receivable, as of June 30, 2016 and December 31, 2015, respectively, are excluded from this disclosure requirement because they are trade receivables in the ordinary course of business where the carrying amount approximates fair value. Included in the total fair value amount are $1.0 billion and $1.2 billion of investments, as of June 30, 2016 and December 31, 2015 for which the fair value is estimated using the net asset value per unit as a practical expedient which are excluded from the disclosure requirement to classify amounts in the fair value hierarchy in connection with the adoption of ASU 2015-07, Disclosure for Investments in Certain Entities That Calculate Net Asset Value per Share (or its Equivalent), on January 1, 2016.
[4]
Includes OTC and OTC-cleared derivative instruments in a net negative fair value position (derivative liability) after consideration of the accrued interest and impact of collateral posting requirements, which may be imposed by agreements, clearing house rules and applicable law.
[5]
Represents hedge funds where investment company accounting has been applied to a wholly-owned fund of funds measured at fair value. The fair value is estimated using the net asset value per unit as a practical expedient and is excluded from the disclosure requirement to classify amounts in the fair value hierarchy in connection with the adoption of ASU 2015-07, Disclosure for Investments in Certain Entities That Calculate Net Asset Value per Share (or its Equivalent), on January 1, 2016.
Information about significant unobservable inputs used in Level 3 assets measured at fair value
Significant Unobservable Inputs for Level 3 Assets Measured at Fair Values (continued)
 
As of June 30, 2016
Freestanding Derivatives
 
 
 
Unobservable Inputs
 
  
Fair
Value
Predominant Valuation
Method
Significant
Unobservable Input
Minimum
Maximum
Impact of
Increase in Input
on Fair Value [1]
Interest rate derivative
 
 
 
 
 
 
Interest rate swaps
$
(34
)
Discounted  cash flows
Swap curve 
beyond 30 years
2%
2%
Decrease
GMWB hedging instruments
 
 
 
 
 
 
Equity variance swaps
(34
)
Option model
Equity volatility
22%
24%
Increase
Equity options
33

Option model
Equity volatility
27%
30%
Increase
Customized swaps
166

Discounted  cash flows
Equity volatility
12%
30%
Increase
Macro hedge program [2]
 
 
 
 
 
 
Equity options
175

Option model
Equity volatility
12%
28%
Increase
 
As of December 31, 2015
Interest rate derivative
 
 
 
 
 
 
Interest rate swaps
$
(30
)
Discounted  cash flows
Swap curve 
beyond 30 years
3%
3%
Decrease
GMWB hedging instruments
 
 
 
 
 
 
Equity variance swaps
(31
)
Option model
Equity volatility
19%
21%
Increase
Equity options
35

Option model
Equity volatility
27%
29%
Increase
Customized swaps
131

Discounted  cash flows
Equity volatility
10%
40%
Increase
Macro hedge program
 
 
 
 
 
 
Equity options
179

Option model
Equity volatility
14%
28%
Increase
[1]
Conversely, the impact of a decrease in input would have the opposite impact to the fair value as that presented in the table. Changes are based on long positions, unless otherwise noted. Changes in fair value will be inversely impacted for short positions.
[2]
Excludes derivatives for which the Company bases fair value on broker quotations as noted in the following discussion.
Significant Unobservable Inputs for Level 3 Assets Measured at Fair Value
The following tables present information about significant unobservable inputs used in Level 3 assets measured at fair value. The tables exclude ABS, CRE CDOs, certain CMBS, corporate and municipal securities as well as index options for which fair values are based on broker quotations.
 
As of June 30, 2016
Securities
 
 
 
Unobservable Inputs
 
Assets accounted for at fair value on a recurring basis
Fair
Value
Predominant
Valuation
Technique
Significant Unobservable  Input
Minimum
Maximum
Weighted Average [1]
Impact of
Increase in Input
on Fair Value [2]
CMBS [3]
$
14

Discounted cash flows
Spread (encompasses
prepayment, default risk and loss severity)
10bps
1,275bps
234bps
Decrease
Corporate [3]
385

Discounted cash flows
Spread
158bps
1,531bps
360bps
Decrease
Municipal [3]
55

Discounted cash flows
Spread
223bps
283bps
240bps
Decrease
RMBS
690

Discounted cash flows
Spread
54bps
1,896bps
205bps
Decrease
 
 
 
Constant prepayment rate
—%
20%
3%
Decrease [4]
 
 
 
Constant default rate
1%
10%
6%
Decrease
 
 
 
Loss severity
—%
100%
79%
Decrease
 
As of December 31, 2015
CMBS [3]
$
61

Discounted cash flows
Spread (encompasses
prepayment, default risk and loss severity)
31bps
1,505bps
230bps
Decrease
Corporate [3]
213

Discounted cash flows
Spread
63bps
800bps
290bps
Decrease
Municipal [3]
31

Discounted cash flows
Spread
193bps
193bps
193bps
Decrease
RMBS
628

Discounted cash flows
Spread
30bps
1,696bps
172bps
Decrease
 
 
 
Constant prepayment rate
—%
20%
3%
Decrease [4]
 
 
 
Constant default rate
1%
10%
6%
Decrease
 
 
 
Loss severity
—%
100%
79%
Decrease
[1]
The weighted average is determined based on the fair value of the securities.
[2]
Conversely, the impact of a decrease in input would have the opposite impact to the fair value as that presented in the table.
[3]
Excludes securities for which the Company bases fair value on broker quotations as noted in the following discussion.
[4]
Decrease for above market rate coupons and increase for below market rate coupons.
 
As of June 30, 2016
Significant Unobservable Input
Minimum
Maximum
Impact of Increase in Input
on Fair Value Measurement [1]
Withdrawal Utilization [2]
20%
100%
Increase
Withdrawal Rates [3]
—%
8%
Increase
Lapse Rates [4]
—%
75%
Decrease
Reset Elections [5]
20%
75%
Increase
Equity Volatility [6]
12%
30%
Increase
 
As of December 31, 2015
Significant Unobservable Input
Minimum
Maximum
Impact of Increase in Input
on Fair Value Measurement [1]
Withdrawal Utilization [2]
20%
100%
Increase
Withdrawal Rates [3]
—%
8%
Increase
Lapse Rates [4]
—%
75%
Decrease
Reset Elections [5]
20%
75%
Increase
Equity Volatility [6]
10%
40%
Increase
[1]
Conversely, the impact of a decrease in input would have the opposite impact to the fair value as that presented in the table.
[2]
Range represents assumed cumulative percentages of policyholders taking withdrawals.
[3]
Range represents assumed cumulative annual amount withdrawn by policyholders.
[4]
Range represents assumed annual percentages of full surrender of the underlying variable annuity contracts across all policy durations for in force business.
[5]
Range represents assumed cumulative percentages of policyholders that would elect to reset their guaranteed benefit base.
[6]
Range represents implied market volatilities for equity indices based on multiple pricing sources.
Generally a change in withdrawal utilization assumptions would be accompanied by a directionally opposite change in lapse rate assumptions, as the behavior of policyholders that utilize GMWB riders is typically different from policyholders that do not utilize these riders.
Roll-forward of Financial Instruments Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Level 3)
Assets and Liabilities Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Level 3)
The following tables provide fair value roll-forwards for the three and six months ended June 30, 2016 for financial instruments classified as Level 3.
For the three months ended June 30, 2016
 
Fixed Maturities, AFS
Fixed Maturities, FVO
Assets
ABS
CDOs
CMBS
Corporate
Foreign Govt./Govt. Agencies
Municipal
RMBS
Total Fixed Maturities, AFS
Fair value as of March 31, 2016
$
2

$
328

$
51

$
538

$
20

$
50

$
701

$
1,690

$
1

Total realized/unrealized gains (losses)
 
 
 
 
 
 
 
 
 
Included in net income [1] [2] [6]

(1
)

(1
)



(2
)

Included in OCI [3]

(1
)
1

16

1

3

3

23


Purchases


3

19


12

40

74


Settlements

(60
)
(4
)
(48
)
(1
)

(44
)
(157
)

Sales


(2
)
(32
)
(2
)


(36
)
(1
)
Transfers into Level 3 [4]
5



263


8


276


Transfers out of Level 3 [4]


(34
)
(38
)


(10
)
(82
)

Fair value as of June 30, 2016
$
7

$
266

$
15

$
717

$
18

$
73

$
690

$
1,786

$

Changes in unrealized gains (losses) included in net income related to financial instruments still held at June 30, 2016 [2] [7]
$

$

$

$
(1
)
$

$

$

$
(1
)
$

 
 
Freestanding Derivatives [5]
Assets (Liabilities)
Equity Securities, AFS
Equity
Interest Rate
GMWB Hedging
Macro Hedge Program
Total Free-Standing Derivatives [5]
Fair value as of March 31, 2016
$
36

$
3

$
(32
)
$
144

$
145

$
260

Total realized/unrealized gains (losses)
 
 
 
 
 
 
Included in net income [1] [2] [6]

(2
)
(2
)
15

(4
)
7

Included in OCI [3]
4






Purchases
2






Settlements






Sales






Transfers into Level 3 [4]






Transfers out of Level 3 [4]



6


6

Fair value as of June 30, 2016
$
42

$
1

$
(34
)
$
165

$
141

$
273

Changes in unrealized gains (losses) included in net income related to financial instruments still held at June 30, 2016 [2] [7]
$

$
(2
)
$
(2
)
$
15

$
(4
)
$
7

Assets
Reinsurance Recoverable for GMWB
Separate Accounts
Fair value as of March 31, 2016
$
99

$
154

Total realized/unrealized gains (losses)
 
 
Included in net income [1] [2] [6]
3


Included in OCI [3]

3

Purchases

22

Settlements
4

(3
)
Sales

(6
)
Transfers into Level 3 [4]

3

Transfers out of Level 3 [4]

(2
)
Fair value as of June 30, 2016
$
106

$
171

Changes in unrealized gains (losses) included in net income related to financial instruments still held at June 30, 2016 [2] [7]
$
3

$

 
Other Policyholder Funds and Benefits Payable
Liabilities
Guaranteed Withdrawal Benefits
Equity Linked Notes
Total Other Policyholder Funds and Benefits Payable
Fair value as of March 31, 2016
$
(361
)
$
(25
)
$
(386
)
Total realized/unrealized gains (losses)
 
 
 
Included in net income [1] [2] [6]
(35
)
(3
)
(38
)
Settlements
(16
)

(16
)
Fair value as of June 30, 2016
$
(412
)
$
(28
)
$
(440
)
Changes in unrealized gains (losses) included in net income related to financial instruments still held at June 30, 2016 [2] [7]
$
(35
)
$
(3
)
$
(38
)
For the six months ended June 30, 2016
  
Fixed Maturities, AFS
Fixed
Maturities,
FVO
Assets
ABS
CDOs
CMBS
Corporate
Foreign
Govt./Govt.
Agencies
Municipal
RMBS
Total Fixed
Maturities,
AFS
Fair value as of January 1, 2016
$
5

$
330

$
62

$
534

$
17

$
49

$
628

$
1,625

$
2

Total realized/unrealized gains (losses)
 
 
 
 
 
 
 
 
 
Included in net income [1] [2] [6]

(1
)

(7
)



(8
)

Included in OCI [3]

(4
)
(1
)
4

2

4

(2
)
3


Purchases


19

34

3

12

148

216

1

Settlements

(59
)
(8
)
(45
)
(2
)

(76
)
(190
)

Sales


(2
)
(35
)
(2
)


(39
)
(1
)
Transfers into Level 3 [4]
5



307


8

2

322


Transfers out of Level 3 [4]
(3
)

(55
)
(75
)


(10
)
(143
)
(2
)
Fair value as of June 30, 2016
$
7

$
266

$
15

$
717

$
18

$
73

$
690

$
1,786

$

Changes in unrealized gains (losses) included in net income related to financial instruments still held at June 30, 2016 [2] [7]
$

$

$

$
(1
)
$

$

$

$

$

 
 
Freestanding Derivatives [5]
Assets (Liabilities)
Equity
Securities,
AFS
Equity
Interest
Rate
GMWB
Hedging
Macro
Hedge
Program
Total Free-
Standing
Derivatives
[5]
Fair value as of January 1, 2016
$
38

$

$
(29
)
$
135

$
147

$
253

Total realized/unrealized gains (losses)
 
 
 
 
 
 
Included in net income [1] [2] [6]

(7
)
(5
)
24

(4
)
8

Included in OCI [3]
4






Purchases
2

8




8

Settlements




(2
)
(2
)
Sales
(2
)





Transfers into Level 3 [4]






Transfers out of Level 3 [4]



6


6

Fair value as of June 30, 2016
$
42

$
1

$
(34
)
$
165

$
141

$
273

Changes in unrealized gains (losses) included in net income related to financial instruments still held at June 30, 2016 [2] [7]
$

$
(7
)
$
(5
)
$
24

$
(4
)
$
8

Assets
Reinsurance Recoverable for GMWB
Separate Accounts
Fair value as of January 1, 2016
$
83

$
139

Total realized/unrealized gains (losses)
 
 
Included in net income [1] [2] [6]
16


Included in OCI [3]

7

Purchases

61

Settlements
7

(9
)
Sales

(16
)
Transfers into Level 3 [4]

6

Transfers out of Level 3 [4]

(17
)
Fair value as of June 30, 2016
$
106

$
171

Changes in unrealized gains (losses) included in net income related to financial instruments still held at June 30, 2016 [2] [7]
$
16

$

 
Other Policyholder Funds and Benefits Payable
Liabilities
Guaranteed
Living
Benefits [7]
Equity Linked
Notes
Total Other
Policyholder Funds
and Benefits Payable
Fair value as of January 1, 2016
$
(262
)
$
(26
)
$
(288
)
Total realized/unrealized gains (losses)
 
 
 
Included in net income [1] [2] [6]
(117
)
(2
)
(119
)
Included in OCI [3]



Settlements
(33
)

(33
)
Fair value as of June 30, 2016
$
(412
)
$
(28
)
$
(440
)
Changes in unrealized gains (losses) included in net income related to financial instruments still held at June 30, 2016 [2] [7]
$
(117
)
$
(2
)
$
(119
)

The following tables provide fair value roll-forwards for the three and six months ended June 30, 2015 for financial instruments classified as Level 3.
For the three months ended June 30, 2015
 
Fixed Maturities, AFS
 
Assets
ABS
CDOs
CMBS
Corporate
Foreign Govt./Govt. Agencies
Municipal
RMBS
Total Fixed Maturities, AFS
Fixed Maturities, FVO
Fair value as of March 31, 2015
$
96

$
362

$
119

$
670

$
17

$
52

$
674

$
1,990

$
72

Total realized/unrealized gains (losses)
 
 
 
 
 
 
 
 
 
Included in net income [1] [2] [6]









Included in OCI [3]
(2
)
(2
)
1

(10
)
(2
)
(3
)
1

(17
)

Purchases
9



2

2


35

48

1

Settlements

(12
)
(13
)
(26
)
(1
)

(29
)
(81
)
1

Sales
(6
)

(3
)
(12
)
(1
)

(35
)
(57
)
(1
)
Transfers into Level 3 [4]






16

16


Transfers out of Level 3 [4]
(83
)

(17
)
(77
)



(177
)
(1
)
Fair value as of June 30, 2015
$
14

$
348

$
87

$
547

$
15

$
49

$
662

$
1,722

$
72

Changes in unrealized gains (losses) included in net income related to financial instruments still held at June 30, 2015 [2] [7]
$

$

$

$

$

$

$

$

$

 
 
Freestanding Derivatives [5]
Assets (Liabilities)
Equity Securities, AFS
Credit
Commodity
Equity
Interest Rate
GMWB Hedging
Macro Hedge Program
Total Free-Standing Derivatives [5]
Fair value as of March 31, 2015
$
48

$
(6
)
$

$
5

$
(30
)
$
159

$
187

$
315

Total realized/unrealized gains (losses)
 
 
 
 
 
 
 
 
Included in net income [1] [2] [6]
6

(2
)
(4
)
(2
)
3

(34
)
(22
)
(61
)
Included in OCI [3]








Purchases
1

(2
)





(2
)
Settlements




(1
)


(1
)
Sales
(8
)







Transfers into Level 3 [4]


6





6

Transfers out of Level 3 [4]
(3
)
10






10

Fair value as of June 30, 2015
$
44

$

$
2

$
3

$
(28
)
$
125

$
165

$
267

Changes in unrealized gains (losses) included in net income related to financial instruments still held at June 30, 2015 [2] [7]
$

$

$
(4
)
$

$
3

$
(32
)
$
(18
)
$
(51
)
Assets
Reinsurance Recoverable for GMWB and Japan GMWB, GMIB, and GMAB
Separate Accounts
Fair value as of March 31, 2015
$
65

$
137

Total realized/unrealized gains (losses)
 
 
Included in net income [1] [2] [6]
(16
)

Included in OCI [3]

(1
)
Purchases

222

Settlements
1

(5
)
Sales

(19
)
Transfers into Level 3 [4]

5

Transfers out of Level 3 [4]

(53
)
Fair value as of June 30, 2015
$
50

$
286

Changes in unrealized gains (losses) included in net income related to financial instruments still held at June 30, 2015 [2] [7]
$
(16
)
$

 
Other Policyholder Funds and Benefits Payable
 
Liabilities
Guaranteed Withdrawal Benefits
Equity Linked Notes
Total Other Policyholder Funds and Benefits Payable
Consumer Notes
Fair value as of March 31, 2015
$
(176
)
$
(26
)
$
(202
)
$
(3
)
Total realized/unrealized gains (losses)
 
 
 
 
Included in net income [1] [2] [6]
78


78


Settlements
(14
)

(14
)

Fair value as of June 30, 2015
$
(112
)
$
(26
)
$
(138
)
$
(3
)
Changes in unrealized gains (losses) included in net income related to financial instruments still held at June 30, 2015 [2] [7]
$
78

$

$
78

$



For the six months ended June 30, 2015
 
Fixed Maturities, AFS
 
Assets
ABS
CDOs
CMBS
Corporate
Foreign
Govt./Govt.
Agencies
Municipal
RMBS
Total Fixed
Maturities,
AFS
Fixed
Maturities,
FVO
Fair value as of January 1, 2015
$
82

$
360

$
119

$
646

$
30

$
54

$
734

$
2,025

$
84

Total realized/unrealized gains (losses)
 
 
 
 
 
 
 
 
 
Included in net income [1] [2] [6]

(1
)

(2
)


(1
)
(4
)
(4
)
Included in OCI [3]
(2
)
13

(1
)
(26
)
(2
)
(5
)
1

(22
)

Purchases
22


12

3

3


46

86

5

Settlements

(18
)
(19
)
(24
)
(2
)

(58
)
(121
)
2

Sales
(6
)

(3
)
(15
)
(14
)

(57
)
(95
)
(5
)
Transfers into Level 3 [4]
1


4

58



16

79


Transfers out of Level 3 [4]
(83
)
(6
)
(25
)
(93
)


(19
)
(226
)
(10
)
Fair value as of June 30, 2015
$
14

$
348

$
87

$
547

$
15

$
49

$
662

$
1,722

$
72

Changes in unrealized gains (losses) included in net income related to financial instruments still held at June 30, 2015 [2] [7]
$

$
(1
)
$
(1
)
$
(1
)
$

$

$

$
(3
)
$
(2
)
 
 
Freestanding Derivatives [5]
Assets (Liabilities)
Equity
Securities,
AFS
Credit
Commodity
Equity
Interest
Rate
GMWB
Hedging
Macro
Hedge
Program
Total Free-Standing Derivatives [5]
Fair value as of January 1, 2015
$
48

$
(3
)
$

$
5

$
(27
)
$
170

$
141

$
286

Total realized/unrealized gains (losses)
 
 

 
 
 
 
 
Included in net income [1] [2] [6]
6

1

(4
)
8


(25
)
(23
)
(43
)
Included in OCI [3]
(2
)







Purchases
3

(8
)




47

39

Settlements



(10
)
(1
)
(20
)

(31
)
Sales
(8
)







Transfers into Level 3 [4]


6





6

Transfers out of Level 3 [4]
(3
)
10






10

Fair value as of June 30, 2015
$
44

$

$
2

$
3

$
(28
)
$
125

$
165

$
267

Changes in unrealized gains (losses) included in net income related to financial instruments still held at June 30, 2015 [2] [7]
$

$
3

$
(4
)
$
1

$
(2
)
$
(16
)
$
(15
)
$
(33
)
Assets
Reinsurance Recoverable for GMWB and Japan GMWB, GMIB, and GMAB
Separate Accounts
Fair value as of January 1, 2015
$
56

$
112

Total realized/unrealized gains (losses)
 
 
Included in net income [1] [2] [6]
(9
)
1

Included in OCI [3]

(1
)
Purchases

260

Settlements
3

(10
)
Sales

(25
)
Transfers into Level 3 [4]

6

Transfers out of Level 3 [4]

(57
)
Fair value as of June 30, 2015
$
50

$
286

Changes in unrealized gains (losses) included in net income related to financial instruments still held at June 30, 2015 [2] [7]
$
(15
)
$
1

 
Other Policyholder Funds and Benefits Payable [1]
 
Liabilities
Guaranteed
Living
Benefits [7][8]
Equity Linked
Notes
Total Other
Policyholder Funds
and Benefits Payable
Consumer
Notes
Fair value as of January 1, 2015
$
(139
)
$
(26
)
$
(165
)
$
(3
)
Total realized/unrealized gains (losses)
 
 
 
 
Included in net income [1] [2] [6]
59


59


Included in OCI [3]




Settlements
(32
)

(32
)

Fair value as of June 30, 2015
$
(112
)
$
(26
)
$
(138
)
$
(3
)
Changes in unrealized gains (losses) included in net income related to financial instruments still held at June 30, 2015 [2] [7]
$
59

$

$
59

$


[1]
The Company classifies realized and unrealized gains and losses on GMWB reinsurance derivatives and GMWB embedded derivatives as unrealized gains (losses) for purposes of disclosure in this table because it is impracticable to track on a contract-by-contract basis the realized gains (losses) for these derivatives and embedded derivatives.
[2]
All amounts in these rows are reported in net realized capital gains (losses). The realized/unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on net income for the Company. All amounts are before income taxes and amortization of DAC.
[3]
All amounts are before income taxes and amortization of DAC.
[4]
Transfers in and/or (out) of Level 3 are primarily attributable to the availability of market observable information and the re-evaluation of the observability of pricing inputs.
[5]
Derivative instruments are reported in this table on a net basis for asset/(liability) positions and reported in the Condensed Consolidated Balance Sheet in other investments and other liabilities.
[6]
Includes both market and non-market impacts in deriving realized and unrealized gains (losses).
[7]
Amounts presented are for Level 3 only and therefore may not agree to other disclosures included herein.

Fair value of assets and liabilities accounted for using the fair value option
Fair Value Option
FVO investments include certain securities that contain embedded credit derivatives with underlying credit risk primarily related to residential and commercial real estate, for which the Company has elected the fair value option. The Company also classifies the underlying fixed maturities held in a consolidated investment fund within the Fixed Maturities, FVO line on the Condensed Consolidated Balance Sheets. The Company reports this consolidated investment company at fair value with changes in the fair value of the underlying securities recognized in net realized capital gains and losses, which is consistent with accounting requirements for investment companies. As of December 31, 2015, the fund held fixed income securities in multiple sectors and the Company had management and control of the funds as well as a significant ownership interest. The Company did not hold any of these funds as of June 30, 2016.
The Company also elected the fair value option for certain equity securities in order to align the accounting with total return swap contracts that hedge the risk associated with the investments. The swaps do not qualify for hedge accounting and the change in value of both the equity securities and the total return swaps are recorded in net realized capital gains and losses. These equity securities are classified within equity securities, AFS on the Condensed Consolidated Balance Sheets. As of June 30, 2016, the Company no longer has any of these investments. Income earned from FVO securities is recorded in net investment income and changes in fair value are recorded in net realized capital gains and losses.
The following table presents the changes in fair value of those assets and liabilities accounted for using the fair value option reported in net realized capital gains and losses in the Company’s Condensed Consolidated Statements of Operations.
 
Three Months Ended June 30,
Six Months Ended June 30,
 
2016
2015
2016
2015
Assets
 
 
 
 
Fixed maturities, FVO
 
 
 
 
Corporate
$

$
(2
)
$

$
1

CDOs



1

Foreign government




RMBS
2

(4
)
2

(3
)
Total fixed maturities, FVO
$
2

$
(6
)
$
2

$
(1
)
Equity, FVO

2

(34
)
2

Total realized capital gains (losses)
$
2

$
(4
)
$
(32
)
$
1

Fair value of assets and liabilities accounted for using the fair value option
The following table presents the fair value of assets and liabilities accounted for using the fair value option included in the Company's Condensed Consolidated Balance Sheets.
 
As of
 
June 30, 2016
December 31, 2015
Assets
 
 
Fixed maturities, FVO
 
 
ABS
$

$
4

Corporate

31

CDOs

1

CMBS

6

Foreign government

1

RMBS
123

119

U.S. Government

3

Total fixed maturities, FVO
$
123

$
165

Equity, FVO
$

$
281



Financial Instruments Not Carried at Fair Value
Financial Instruments Not Carried at Fair Value
The following table presents carrying amounts and fair values of the Company's financial instruments not carried at fair value.
 
 
June 30, 2016
December 31, 2015
 
Fair Value Hierarchy Level
Carrying Amount
Fair Value
Carrying Amount
Fair Value
Assets
 
 
 
 
 
Policy loans
Level 3
$
1,434

$
1,434

$
1,446

$
1,446

Mortgage loans
Level 3
2,871

3,053

2,918

2,995

Liabilities
 
 
 
 
 
Other policyholder funds and benefits payable [1]
Level 3
$
6,390

$
6,682

$
6,611

$
6,802

Consumer notes [2] [3]
Level 3
32

32

38

38

Assumed investment contracts [3]
Level 3
738

795

619

682

[1]
Excludes group accident and health and universal life insurance contracts, including corporate owned life insurance.
[2]
Excludes amounts carried at fair value and included in preceding disclosures.
[3]
Included in other liabilities in the Condensed Consolidated Balance Sheets.